RecruitingNot ApplicableNCT06921967

Effect of Corneal and Scleral RGP Lenses on Ocular Health and Visual Quality in Keratoconus

A Comparison of Ocular Health and Visual Quality With Corneal and Scleral Rigid Gas Permeable Lenses in Keratoconus Patients


Sponsor

University of Aarhus

Enrollment

50 participants

Start Date

Aug 15, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to compare the ocular health and visual quality of corneal rigid gas permeable lenses (CRGPL) and scleral rigid gas permeable lenses (SRGPL) for patients with keratoconus in a crossover clinical trial. The study will analyze subjective and objective outcomes, including best corrected visual acuity, contrast sensitivity, higher-order aberrations and subjective perception of visual function and comfort. It will also investigate the impact of both lens types on the health of the ocular surface, including evaluation of corneal, conjunctival, and scleral tissues, and tear film. Only one randomized controlled trial has compared the effect of CRGPL and SRGPL wear for patients with an ectatic corneal disorder. With the increasing popularity of SRGPL, examining the differences in efficacy, safety, and patient-reported outcomes between the two types of lenses is increasingly relevant.


Eligibility

Min Age: 18 YearsMax Age: 40 Years

Inclusion Criteria1

  • Keratoconus, best spectacle corrected visual acuity \>0.00 log of minimum angle of resolution (logMAR) and age between 18 to 40

Exclusion Criteria1

  • K-max \>60D, RGP lens wear at baseline and ocular surface disease, verified through examination of the ocular surface and patient history

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICERose K2

Corneal RGP lens with flexible parameters.

DEVICEOnefit MED

Scleral RGP lens with flexible parameters.


Locations(1)

Aarhus University Hospital

Aarhus, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06921967


Related Trials